Home » Newsletters » BioWorld Science

BioWorld Science

April 22, 2002

View Archived Issues

Dose-dependent improvement on rotigotine CDS in Parkinson's patients

Altocor filed for European marketing approval

Name change for inhalation technology company

Novel therapy to reduce or eliminate insulin dependence proves effective in NOD mice

Compounds with anticonvulsant activity prepared and tested at Arzneimittelwerk Dresden

Lead Androgenics compound blocks androgen receptor activation at an early step

CKD-732 examined for pharmacokinetic and metabolic profile in vitro and in vivo

All four components of PHY-906 necessary for biological activity as chemotherapy adjuvant

Small-molecule inhibitors of FAH designed at Bayer as potential agents for NSCLC

Small-molecule GnRH antagonist with good oral bioavailability presented at AACR meeting

Takeda presents new orally active antitumor agent for HER2-positive cancers

CTLA4-Ig cleared to enter phase I/II trial in ITP

Phase III trial of Affinitac in combination with Gemzar/cisplatin in NSCLC

Aquavan completes phase I study, safely achieves loss of consciousness

Ampligen evaluated in two new HIV/AIDS trials

Patient enrollment completed in phase II trial of interferon omega in chronic hepatitis C

Tularik presents first-quarter 2002 results

Broad-spectrum antimicrobial agents described by Chiron

Oxazolidinones patented by Abbott for bacterial infections, etc.

Tricyclic protein farnesyltransferase inhibitors with antiproliferative activity

New Chiron compounds reportedly useful for angiogenesis-related conditions

Roche designs new p38 kinase inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...